Metraipolis › archive › dc_34975609cf2c
Poloxamer-Based Biomaterial as a Pharmaceutical Strategy to Improve the Ivermectin Performance — Europe PMC PMID:41012440
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41012440
- DOI
- 10.3390/pharmaceutics17091101
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T09:57:19.927Z
- SHA-256 of the archived text
e68b9f3db0e2d4a99f99eeaa785a46ab33085f17441ea1915eef2d25c838fde4- Stable URL of this page
https://metraipolis.com/documento/dc_34975609cf2c
How to cite
Poloxamer-Based Biomaterial as a Pharmaceutical Strategy to Improve the Ivermectin Performance — Europe PMC PMID:41012440 — Europe PMC (en), https://europepmc.org/article/MED/41012440 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_34975609cf2c (Metraipolis archive dc_34975609cf2c, sha256 e68b9f3db0e2d4a99f99eeaa785a46ab33085f17441ea1915eef2d25c838fde4)
BibTeX
@misc{dc34975609cf2c,
title = {Poloxamer-Based Biomaterial as a Pharmaceutical Strategy to Improve the Ivermectin Performance — Europe PMC PMID:41012440},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41012440},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_34975609cf2c; sha256 e68b9f3db0e2d4a99f99eeaa785a46ab33085f17441ea1915eef2d25c838fde4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012440. Agents can read the archived copy with the MCP tool read_document.